Total lesion area of >12 DA or >30.5 mm2
The existence of subretinal hemorrhage area constituting =50% of total lesion area
The existence of scar or fibrosis area constituting =50% of total lesion area
The existence of RPE tear
Prior treatment for wet AMD
History of vitrectomy surgery, submacular surgery, or other surgical intervention for AMD
The pregnant or lactating woman

NCT02321839_exc_T1
Measurement
Total lesion area
NCT02321839_exc_T2
Value
>12 DA
NCT02321839_exc_T3
Value
>30.5 mm2
NCT02321839_exc_T4
Scope
>12 DA or >30.5 mm2
NCT02321839_exc_T5
Measurement
subretinal hemorrhage area
NCT02321839_exc_T6
Value
=50% of total lesion area
NCT02321839_exc_T7
Measurement
ar o ea c
NCT02321839_exc_T8
Measurement
fibrosis area
NCT02321839_exc_T9
Scope
scar or fibrosis area
NCT02321839_exc_T10
Value
=50% of total lesion area
NCT02321839_exc_T11
Condition
RPE tear
NCT02321839_exc_T12
Temporal
Prior
NCT02321839_exc_T13
Procedure
treatment
NCT02321839_exc_T14
Procedure
vitrectomy surgery
NCT02321839_exc_T15
Procedure
submacular surgery
NCT02321839_exc_T16
Procedure
surgical intervention
NCT02321839_exc_T17
Qualifier
other
NCT02321839_exc_T18
Condition
AMD
NCT02321839_exc_T19
Scope
vitrectomy surgery, submacular surgery, or other surgical intervention
NCT02321839_exc_T20
Condition
pregnant
NCT02321839_exc_T21
Condition
lactating
NCT02321839_exc_T22
Person
woman